Products for Research Use Only

β-Caryophyllene-13C, d2

CAT: 0804-HY-N1415S1Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-N1415S1Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
β-Caryophyllene-13C, d2 is 13C and deuterated labeled β-Caryophyllene. β-Caryophyllene is a CB2 receptor agonist[1].
Product Name Alternative
(-) - (E) -Caryophyllene-13C, d2; (−) -β-caryophyllene-13C, d2; (−) -trans-Caryophyllene-13C, d2
UNSPSC
12352211
Target
Cannabinoid Receptor; Endogenous Metabolite; Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling; Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Solubility
10 mM in DMSO
Smiles
CC1([C@@]2([H])[C@](/C(CC/C=C(CC2)/C)=[13C]([2H])\[2H])([H])C1)C
Molecular Formula
C14 13CH22D2
Molecular Weight
207.36
References & Citations
[1]Cheng Y, et al. β-Caryophyllene ameliorates the Alzheimer-like phenotype in APP/PS1 Mice through CB2 receptor activation and the PPARγ pathway. Pharmacology. 2014;94 (1-2) :1-12.|[2]Dahham SS, et al. The Anticancer, Antioxidant and Antimicrobial Properties of the Sesquiterpene β-Caryophyllenefrom the Essential Oil of Aquilaria crassna. Molecules. 2015 Jun 26;20 (7) :11808-29.|[3]de Oliveira CC, et al. Anticonvulsant activity of β-caryophyllene against pentylenetetrazol-induced seizures. Epilepsy Behav. 2016 Mar;56:26-31.|[4]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported

Popular Products